Caldera Health asks men to give biopsy samples to help prove up prostate cancer test

Caldera Health asks men to give biopsy samples to help prove up prostate cancer test
By Fiona Rotherham Sept. 8 (BusinessDesk) - Caldera Health, a New Zealand biotech company working on a gene-sequencing replacement for the world’s most widely used prostate cancer test, is seeking more biopsy samples from Kiwi men to help prove its concept. Caldera managing director Graham Watt said he wants at least 50 samples by the end of the year though would eventually like to build up to at least 200 to help prove the credibility of its proprietary gene-sequencing test. The medical diagnostic firm has been receiving a few samples...